Danielle Beaumont

4.4k total citations
17 papers, 433 citations indexed

About

Danielle Beaumont is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Physiology. According to data from OpenAlex, Danielle Beaumont has authored 17 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 4 papers in Pharmacology and 4 papers in Physiology. Recurrent topics in Danielle Beaumont's work include Maternal and fetal healthcare (4 papers), Respiratory and Cough-Related Research (3 papers) and Allergic Rhinitis and Sensitization (3 papers). Danielle Beaumont is often cited by papers focused on Maternal and fetal healthcare (4 papers), Respiratory and Cough-Related Research (3 papers) and Allergic Rhinitis and Sensitization (3 papers). Danielle Beaumont collaborates with scholars based in United Kingdom, France and Pakistan. Danielle Beaumont's co-authors include Haleema Shakur‐Still, Katharine Ker, Angèle Gayet‐Ageron, H. Mousa, Sue Pavord, Ian Roberts, A Taytard, Marc Sapène, Danielle Prowse and Jane Armitage and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Journal of Allergy and Clinical Immunology and BMJ.

In The Last Decade

Danielle Beaumont

17 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle Beaumont United Kingdom 11 129 107 104 70 65 17 433
Marcelo Orías Argentina 13 88 0.7× 34 0.3× 27 0.3× 82 1.2× 18 0.3× 39 647
Dariusz A. Kosior Poland 18 144 1.1× 33 0.3× 15 0.1× 44 0.6× 21 0.3× 98 1.1k
Jean-Philippe Kévorkian France 11 333 2.6× 100 0.9× 76 0.7× 37 0.5× 27 763
Claire Heslop Canada 12 140 1.1× 35 0.3× 9 0.1× 86 1.2× 4 0.1× 21 566
Colin Millar United Kingdom 9 100 0.8× 122 1.1× 49 0.5× 86 1.2× 1 0.0× 16 483
M. Christiansen Denmark 11 54 0.4× 33 0.3× 21 0.2× 48 0.7× 4 0.1× 19 500
Seftel Hc South Africa 11 143 1.1× 39 0.4× 34 0.3× 37 0.5× 7 0.1× 54 442
Michael J. Apostolakos United States 12 65 0.5× 43 0.4× 12 0.1× 145 2.1× 5 0.1× 25 495
Maciej Haberka Poland 20 209 1.6× 101 0.9× 14 0.1× 115 1.6× 3 0.0× 77 899
Adi J. Klil‐Drori Canada 12 64 0.5× 46 0.4× 16 0.2× 60 0.9× 2 0.0× 26 483

Countries citing papers authored by Danielle Beaumont

Since Specialization
Citations

This map shows the geographic impact of Danielle Beaumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Beaumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Beaumont more than expected).

Fields of papers citing papers by Danielle Beaumont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Beaumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Beaumont. The network helps show where Danielle Beaumont may publish in the future.

Co-authorship network of co-authors of Danielle Beaumont

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Beaumont. A scholar is included among the top collaborators of Danielle Beaumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Beaumont. Danielle Beaumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ker, Katharine, Raoul Mansukhani, Haleema Shakur‐Still, et al.. (2023). Tranexamic acid for gastrointestinal bleeding: can a reduction in the risk of death be discounted? A systematic review and meta-analysis of individual patient data from 64 724 bleeding patients. BMJ Open. 13(2). e059982–e059982. 3 indexed citations
2.
Roberts, Ian, Haleema Shakur‐Still, A Aeron-Thomas, et al.. (2021). Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT. Health Technology Assessment. 25(26). 1–76. 23 indexed citations
3.
Herrett, Emily, Elizabeth Williamson, Kieran E. Brack, et al.. (2021). Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials. BMJ. 372. n135–n135. 114 indexed citations
4.
Herrett, Emily, Elizabeth Williamson, Kieran E. Brack, et al.. (2021). The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs. Health Technology Assessment. 25(16). 1–62. 3 indexed citations
5.
Picetti, Roberto, Lori Miller, Haleema Shakur‐Still, et al.. (2020). The WOMAN trial: clinical and contextual factors surrounding the deaths of 483 women following post-partum haemorrhage in developing countries. BMC Pregnancy and Childbirth. 20(1). 409–409. 23 indexed citations
6.
Picetti, Roberto, Haleema Shakur‐Still, Tracey Pepple, et al.. (2020). The WOMAN Trial: Clinical and Contextual Factors Surrounding the Deaths of 483 Women Following Post-Partum Hemorrhage in Developing Countries. Obstetrical & Gynecological Survey. 75(12). 723–725. 3 indexed citations
7.
Ker, Katharine, Ian Roberts, Rizwana Chaudhri, et al.. (2018). Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial. Trials. 19(1). 712–712. 34 indexed citations
8.
Shakur‐Still, Haleema, Danielle Beaumont, Sue Pavord, et al.. (2018). Antifibrinolytic drugs for treating primary postpartum haemorrhage. Cochrane Database of Systematic Reviews. 2018(2). 203–205. 85 indexed citations
9.
Herrett, Emily, Elizabeth Williamson, Danielle Beaumont, et al.. (2017). Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care. BMJ Open. 7(12). e016604–e016604. 13 indexed citations
10.
Beaumont, Danielle, et al.. (2014). Good clinical practice in trauma care research: Considerations for inter-hospital patient transfers. International Emergency Nursing. 23(1). 42–44. 3 indexed citations
11.
Brion, N, Emmanuel Naline, Danielle Beaumont, M Pays, & Charles Advenier. (1989). Lack of effect of terfenadine on theophylline pharmacokinetics and metabolism in normal subjects.. British Journal of Clinical Pharmacology. 27(3). 391–395. 4 indexed citations
12.
Badier, M., Danielle Beaumont, & J Orehek. (1988). Attenuation of hyperventilation-induced bronchospasm by terfenadine: A new antihistamine. Journal of Allergy and Clinical Immunology. 81(2). 437–440. 21 indexed citations
13.
Brion, N, Danielle Beaumont, & Charles Advenier. (1988). Evaluation of the antimuscarinic activity of atropine, terfenadine and mequitazine in healthy volunteers.. British Journal of Clinical Pharmacology. 25(1). 27–32. 15 indexed citations
14.
Taytard, A, et al.. (1987). Treatment of bronchial asthma with terfenadine; a randomized controlled trial.. British Journal of Clinical Pharmacology. 24(6). 743–746. 60 indexed citations
15.
Sapène, Marc, Danielle Beaumont, & A Taytard. (1987). [Asthma and synthetic antihistaminics].. PubMed. 4(6). 295–9. 3 indexed citations
16.
Hugonot, R, et al.. (1987). Multi-Centre Double-Blind Comparison of Terfenadine Once Daily versus Twice Daily in Patients with Hay Fever. Journal of International Medical Research. 15(4). 212–223. 11 indexed citations
17.
Hugonot, R, et al.. (1986). A Double-Blind Comparison of Terfenadine and Mequitazine in the Symptomatic Treatment of Acute Pollinosis. Journal of International Medical Research. 14(3). 124–130. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcelo Orías Breakdown of academic impact, for papers by Dariusz A. Kosior Breakdown of academic impact, for papers by Jean-Philippe Kévorkian Breakdown of academic impact, for papers by Claire Heslop Breakdown of academic impact, for papers by Colin Millar Breakdown of academic impact, for papers by M. Christiansen Breakdown of academic impact, for papers by Seftel Hc Breakdown of academic impact, for papers by Michael J. Apostolakos Breakdown of academic impact, for papers by Maciej Haberka Breakdown of academic impact, for papers by Adi J. Klil‐Drori
Rankless by CCL
2026